Provided by Tiger Trade Technology Pte. Ltd.

ProMIS Neurosciences Inc

8.92
-0.4200-4.50%
Post-market: 8.970.0500+0.56%16:52 EST
Volume:17.33K
Turnover:156.08K
Market Cap:19.20M
PE:-0.44
High:9.13
Open:9.02
Low:8.89
Close:9.34
52wk High:39.75
52wk Low:6.27
Shares:2.15M
Float Shares:1.02M
Volume Ratio:0.68
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-20.0495
EPS(LYR):2.68
ROE:-355.80%
ROA:-85.38%
PB:2.09
PE(LYR):3.33

Loading ...

ProMIS Neurosciences Advances PMN310 Alzheimer’s Trial With Interim Results Expected in 2026

Reuters
·
Dec 10

ProMIS Neurosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 02

BRIEF-Plasma pTau Identified as Key Early Endpoint in Alzheimer's Research

Reuters
·
Dec 01

ProMIS Neurosciences Announces Interim Phase 1b Trial Readout for PMN310 in Alzheimer's Disease Set for Q2 2026

Reuters
·
Dec 01

ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma Ptau as a Predictive Early Endpoint in Alzheimer’s Trials, Supporting Its Ongoing Phase 1B Precise-Ad Trial With Pmn310

THOMSON REUTERS
·
Dec 01

ProMIS Neurosciences CEO to Join Fireside Chat at Evercore Healthcare Conference

Reuters
·
Dec 01

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Reuters
·
Nov 27

Promis Neurosciences Inc trading halted, news pending

TIPRANKS
·
Nov 27

Analysts Offer Insights on Healthcare Companies: ProMIS Neurosciences (PMN) and Crispr Therapeutics AG (CRSP)

TIPRANKS
·
Nov 26

Nasdaq Surges 350 Points; Enlivex Therapeutics Shares Spike Higher

Benzinga
·
Nov 24

ProMIS Neurosciences Announces 1-for-25 Reverse Stock Split

Reuters
·
Nov 24

ProMIS Neurosciences Announces Reverse Stock Split

THOMSON REUTERS
·
Nov 24

ProMIS Neurosciences Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
Nov 21

PTS Announces Official Launch of PMN on Republic -- Japan's First Compliant STO Offered in the United States

prnewswire
·
Nov 21

ProMIS Neurosciences Inc. held special shareholder meeting

Reuters
·
Nov 19

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and ProMIS Neurosciences (PMN)

TIPRANKS
·
Nov 19

ProMIS Neurosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Nov 18

ProMIS Neurosciences price target lowered to $5 from $6 at Guggenheim

TIPRANKS
·
Nov 18

ProMIS Neurosciences Reports Increased Cash Position and Progress in Alzheimer's Trial

Reuters
·
Nov 12

ProMIS Neurosciences posts Q3 loss of $11.8 million on increased clinical trial spending

Reuters
·
Nov 12